Oral Sildenafil for Macrocystic Lymphangioma in a Filipino Child: A Case Report
Ma. Denisse R. Fernandez, Maria Lourdes H. Palmero
Oct 2025 DOI 10.35460/2546-1621.2025-0032 Access
Abstract
Lymphangioma is a rare developmental anomaly of the lymphatic system, commonly arising at birth, in infancy, or early childhood. Treatment is rarely curative. We report a case of macrocystic lymphangioma treated with sildenafil in a 16-year-old Filipino child diagnosed clinically, radiologically and histologically. The patient presented with grouped papulovesicles on the left lower extremity, associated with limb length discrepancy, unilateral leg pain and difficulty in ambulation. Given the recurrent course of this condition, even with surgical management, the use of a non-invasive approach such as sildenafil as a potential treatment option for lymphangioma is an important emerging area of study.
- García-Montero P, Del Boz J, Sanchez-Martínez M, Escudero Santos IM, Baselga E. Microcystic lymphatic malformation successfully treated with topical rapamycin. Pediatrics [Internet]. 2017;139(5):e20162105. Available from: https://doi.org/10.1542/peds.2016-2105. PubMed PMID: 28557723
- Chen EY, Hostikka SL, Oliaei S, Duke W, Schwartz SM, Perkins JA. Similar histologic features and immunohistochemical staining in microcystic and macrocystic lymphatic malformations. Lymphat Res Biol [Internet]. 2009;7(2):75–80. Available from: https://doi.org/10.1089/lrb.2009.0003. PMID: 19534631.
- Gandhi NG, Lin LK, O’Hara M. Sildenafil for pediatric orbital lymphangioma. JAMA Ophthalmol [Internet]. 2013;131(9):1228–30. Available from: https://doi.org/10.1001/jamaophthalmol.2013.4201. PubMed PMID: 23828510
- Danial C, Tichy AL, Tariq U, Swetman GL, Khuu P, Leung TH, et al. An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. J Am Acad Dermatol [Internet]. 2014;70(6):1050–7. Available from: https://doi.org/10.1016/j.jaad.2014.02.005. PubMed PMID: 24656411; PubMed Central PMCID: PMC4024322
- Huang JT, Liang MG. Vascular malformations. In: Drolet B, Garzon M, editors. Birthmarks of clinical significance. New York: Pediatric Clinics of North America; 2010 p.1091–110
- Kudur MH, Hulmani M. Extensive and invasive lymphangioma circumscriptum in a young female: A rare case report and review of the literature. Indian Dermatol Online J [Internet]. 2013;4(3):199–201. Available from: https://doi.org/10.4103/2229-5178.115516. PubMed PMID: 23984233; PubMed Central PMCID: PMC3752475
- Shankar VN. Lymphvasculogenesis and Lymphangioma–an Update. J Cancer Sci Ther [Internet]. 2011;03(06). Available from: https://doi.org/10.4172/1948-5956.1000078
- Enjolras O, Soupre V, Picard A. Classification of superficial vascular anomalies. Presse Med [Internet]. 2010;39(4):457–64. Available from: https://doi.org/10.1016/j.lpm.2009.07.029. PubMed PMID: 20206462
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0
International License, which permits use, share — copy and redistribute the material in any medium or format,
adapt — remix, transform, and build upon the material, as long as you give appropriate credit,
provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner,
but not in any way that suggests the licensor endorses you or your use. You may not use the material for
commercial purposes. If you remix, transform, or build upon the material, you must distribute your
contributions under the same license as the original. You may not apply legal terms or technological
measures that legally restrict others from doing anything the license permits. The images or other
third party material in this article are included in the article’s Creative Commons license, unless indicated
otherwise in a credit line to the material. If material is not included in the article’s Creative Commons
license and your intended use is not permitted by statutory regulation or exceeds the permitted use,
you will need to obtain permission directly from the copyright holder. To view a copy of this license,
visit https://creativecommons.org/licenses/by-nc-sa/4.0/.
